- Home
- PRTA vs URG Comparison
PRTA vs URG Comparison
Compare PRTA & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- URG
- Stock Information
- Founded
- PRTA 2012
- URG 2004
- Country
- PRTA Ireland
- URG United States
- Employees
- PRTA N/A
- URG N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- PRTA Health Care
- URG Basic Materials
- Exchange
- PRTA Nasdaq
- URG Nasdaq
- Market Cap
- PRTA 366.6M
- URG 419.5M
- IPO Year
- PRTA N/A
- URG N/A
- Fundamental
- Price
- PRTA $7.69
- URG $1.22
- Analyst Decision
- PRTA Buy
- URG Strong Buy
- Analyst Count
- PRTA 10
- URG 3
- Target Price
- PRTA $24.29
- URG $2.63
- AVG Volume (30 Days)
- PRTA 955.8K
- URG 5.2M
- Earning Date
- PRTA 08-04-2025
- URG 08-05-2025
- Dividend Yield
- PRTA N/A
- URG N/A
- EPS Growth
- PRTA N/A
- URG N/A
- EPS
- PRTA N/A
- URG N/A
- Revenue
- PRTA $10,341,000.00
- URG $39,488,000.00
- Revenue This Year
- PRTA N/A
- URG N/A
- Revenue Next Year
- PRTA $122.46
- URG $224.22
- P/E Ratio
- PRTA N/A
- URG N/A
- Revenue Growth
- PRTA N/A
- URG 149.20
- 52 Week Low
- PRTA $4.32
- URG $0.55
- 52 Week High
- PRTA $23.66
- URG $1.42
- Technical
- Relative Strength Index (RSI)
- PRTA 70.62
- URG 50.13
- Support Level
- PRTA $6.61
- URG $1.19
- Resistance Level
- PRTA $8.01
- URG $1.30
- Average True Range (ATR)
- PRTA 0.40
- URG 0.07
- MACD
- PRTA 0.10
- URG -0.02
- Stochastic Oscillator
- PRTA 81.40
- URG 29.31
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.